January has been a big month for biotech, with the JP Morgan conference dominating the start of the year. The conference traditionally brings about a host of deals and new buys, and this latest Vycor pick up suggests there’s plenty more to come before the end of the month.
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Vycor Medical Inc. (OTCMKTS:VYCO) reported that Fountainhead Capital Management Ltd. has picked up 9,733,832 of common stock as of 2017-01-20.
The acquisition brings the aggregate amount owned by Fountainhead Capital Management Ltd. to a total of 9,733,832 representing a 55.74% stake in the company.
For those not familiar with the company, Vycor Medical, Inc. provides surgical and therapeutic solutions. The Company operates through two segments: Vycor Medical, which focuses on brain and cervical surgical access systems for sale to hospitals and medical professionals, and NovaVision, which focuses on neuro-stimulation therapies and diagnostic devices for the treatment and screening of vision field loss resulting from neurological damage. The Company designs, develops and markets neurological medical devices and therapies. The Company operates in the United States and Europe. Vycor Medical’s product Vycor Medical’s ViewSite Brain Access System (VBAS) is a next generation retraction and access system. VBAS is a disposable product that can be used with microscopic, endoscopic and neuro-navigation systems.
A glance at Vycor Medical Inc. (OTCMKTS:VYCO)’s key stats reveals a current market capitalization of 2.82 million based on 11.22 million shares outstanding and a price at last close of $0.250 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2014-12-31, Fountainhead picked up 8,380 at a purchase price of $1.79. This brings their total holding to 4,366,844 as of the date of the filing.
On the sell side, the most recent transaction saw Bronsther unload 6,241 shares at a sale price of $2.75. This brings their total holding to 18,216.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Vycor Medical Inc. (OTCMKTS:VYCO) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
